Feb 21, 2017 12:05 pm UTC| Business
INDIANAPOLIS, Feb. 21, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Cellect Announces Positive Clinical Trial Results
Feb 21, 2017 12:02 pm UTC| Business
ApoGraft TM, Cellect’s flagship technology, validated as safe, robust and reproducible process for clinical use after a 104 donor test base Cellect CEO: “In plain words, these positive results bring us one step closer to...
Feb 21, 2017 12:02 pm UTC| Business
SAN DIEGO, Feb. 21, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that it will publish financial results for the fourth quarter and...
Feb 21, 2017 12:02 pm UTC| Business
SAN DIEGO, Feb. 21, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that it will publish financial results for the fourth quarter and...
Feb 21, 2017 12:01 pm UTC| Business
- Industry veteran to lead development of optimized programs for Iomab-B including initiatives targeted at patients, physicians and payors designed to support clinical development and pre-commercialization efforts - Mr....
Feb 21, 2017 12:01 pm UTC| Business
SAN DIEGO, Feb. 21, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that it will publish financial results for the fourth quarter and...
Feb 21, 2017 12:01 pm UTC| Business
BERKELEY HEIGHTS, N.J., Feb. 21, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening...
Trump Says Ukraine Peace Deal ‘Closer,’ But Key Disputes Remain Unresolved